Real World Performance of an Individualized Antitachycardia Pacing Algorithm
Journal of Cardiovascular Electrophysiology · 2025
DOI: 10.1111/jce.16747 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cardiovascular Electrophysiology, 2025. Verfasst von Troy Jackson und 6 weiteren Autor:innen. Beteiligte Einrichtung: Medtronic Inc., Mounds View, Minnesota, USA. Hauptthemen laut MEDLINE: Algorithms, Tachycardia, Ventricular, Cardiac Pacing, Artificial, Heart Rate. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: This study was supported by Medtronic., Medtronic.
Abstract (Originalsprache)
Background
A novel individualized antitachycardia pacing (IATP) algorithm using the post‐pacing interval for real‐time control has been introduced. Performance information is limited to a small safety and feasibility study with additional single‐center and case studies. A larger‐scale analysis is needed to better understand algorithm performance.
Methods
Deidentified remote monitoring transmissions from devices with the IATP therapy applied were randomly selected. Rhythms were classified and effects of the novel algorithm were assessed. For monomorphic ventricular tachycardias (MVTs) proportions of successful therapy, shock‐free episodes, and acceleration were calculated using generalized estimating equations to correct for multiple episodes and compute statistics of the algorithm's performance.
Results
There were 2259 MVT episodes in 336 patients. IATP succeeded in 87.1% of MVT episodes with 89.9% of MVT episodes ultimately free of shock therapy. Based on multivariate analysis, significant factors in therapy success were programming of at least the recommended number of sequences (90% at least recommended vs 73%, p = 0.00088) and female sex (95% for females vs 86%, p = 0.002). A trend to higher success was found for MVT with a cycle length of 320 ms or greater (90% vs. 83%, p = 0.10). The IATP accelerated 3.6% of MVT episodes. None of the available factors was significantly associated with acceleration in the multivariate analysis.
Conclusions
The IATP algorithm succeeded in a large proportion of MVT episodes and with low acceleration in patients randomly selected from remote monitoring transmissions. Using at least the recommended number of sequences had the strongest association with successful therapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medtronic Inc., Mounds View, Minnesota, USA.
- Department of Medicine, Western University, London, Ontario, Canada.
- Department of Medicine, Cardiovascular Institute La Jolla, University of California San Diego, San Diego, California, USA.
- Department of Cardiovascular Medicine Rochester, Mayo Clinic, Rochester, Minnesota, USA.
- Harvard Medical School, Cardiac Arrhythmia Service Boston, Boston, Massachusetts, USA.
ORCID-Profile: Troy Jackson, Ulrika Birgersdotter-Green, Yong-Mei Cha
Förderung
- This study was supported by Medtronic.
- Medtronic
Zitieren
APA
Jackson, T., Yee, R., Taepke, R., Cheng, A., Birgersdotter-Green, U., Cha, Y. M., & Singh, J. (2025). Real World Performance of an Individualized Antitachycardia Pacing Algorithm. Journal of Cardiovascular Electrophysiology. https://doi.org/10.1111/jce.16747
Vancouver
Jackson T, Yee R, Taepke R, Cheng A, Birgersdotter-Green U, Cha YM, et al. Real World Performance of an Individualized Antitachycardia Pacing Algorithm. Journal of Cardiovascular Electrophysiology. 2025. doi:10.1111/jce.16747
BibTeX
@article{Jackson2025,
author = {Jackson, Troy and Yee, Raymond and Taepke, Robert and Cheng, Alan and Birgersdotter-Green, Ulrika and Cha, Yong-Mei and Singh, Jagmeet},
title = {Real World Performance of an Individualized Antitachycardia Pacing Algorithm},
journal = {Journal of Cardiovascular Electrophysiology},
year = {2025},
doi = {10.1111/jce.16747}
}
EUVIMED